Alerts will be sent to your verified email
Verify Email
OXYGENTAPH
|
Oxygenta Pharma
|
Nectar Lifesciences
|
Influx Healthtech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.1 % | -0.71 % | 61.78 % |
|
5yr average Equity Multiplier
|
-1.22 | 2.17 | 2.53 |
|
5yr Average Asset Turnover Ratio
|
1.1 | 0.74 | 2.5 |
|
5yr Avg Net Profit Margin
|
-16.74 % | -0.63 % | 10.21 % |
|
Price to Book
|
0.0 | 0.38 | 9.93 |
|
P/E
|
0.0 | 0.0 | 26.88 |
|
5yr Avg Cash Conversion Cycle
|
-56.32 Days | 81.28 Days | -66.58 Days |
|
Inventory Days
|
94.46 Days | 136.26 Days | 16.45 Days |
|
Days Receivable
|
80.66 Days | 62.43 Days | 84.17 Days |
|
Days Payable
|
174.19 Days | 113.03 Days | 128.24 Days |
|
5yr Average Interest Coverage Ratio
|
-3.11 | 0.94 | 988.18 |
|
5yr Avg ROCE
|
-80.86 % | 7.51 % | 82.15 % |
|
5yr Avg Operating Profit Margin
|
-18.99 % | 7.57 % | 15.28 % |
|
5 yr average Debt to Equity
|
-1.55 | 0.73 | 0.06 |
|
5yr CAGR Net Profit
|
-9.68 % | -31.15 % | 24.67 % |
|
5yr Average Return on Assets
|
-10.42 % | -0.34 % | 24.24 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
57.92 % | 44.53 % | n/a |
|
Share Pledged by Promoters
|
0.0 | 99.6 % | n/a |
|
Change in Promoter Holding (3 Yrs)
|
45.59 % | -11.27 % | n/a |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.04 % | 0.0 | n/a |
|
Oxygenta Pharma
|
Nectar Lifesciences
|
Influx Healthtech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|